methamphetamine has been researched along with Hyperactivity, Motor in 65 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 7 (10.77) | 18.7374 |
1990's | 5 (7.69) | 18.2507 |
2000's | 25 (38.46) | 29.6817 |
2010's | 28 (43.08) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Mihalčíková, L; Ochozková, A; Šlamberová, R; Yamamotová, A | 1 |
Chen, ML; Chen, YH; Chen, YW; Hsieh, W; Lin, CM; Tsai, HM; Wang, Y; Wu, KJ; Wu, KL | 1 |
Cong, B; Gou, HY; Li, F; Li, J; Su, RB; Sun, X; Wang, ZY; Wu, N | 1 |
Bu, Q; Cen, X; Gu, H; Guo, W; Jiang, L; Kong, J; Li, Y; Long, H; Luo, L; Shao, X; Tian, J; Zhao, Y; Zhu, R | 1 |
Brunner, SM; Djouma, E; Genders, SG; Jaehne, EJ; Kofler, B; Lawrence, AJ; Scheller, KJ; Turner, BJ; van den Buuse, M | 1 |
Chen, YW; Kao, HY; Lai, WS; Min, MY | 1 |
Aarde, SM; Creehan, KM; Dickerson, TJ; Huang, PK; Taffe, MA | 1 |
Chen, N; Cooper, H; Flores, C; Kim, JH; Lavan, D; Lawrence, AJ | 1 |
Fukunari, A; Kajii, Y; Kano, S; Kondo, MA; Miwa, K; Ohzeki, H; Okada, K; Sakaue, M; Sawa, A; Takemoto, K; Tamura, M; Tezuka, T; Yasumatsu, H | 1 |
Beaulieu, JM; Del'Guidice, T; Escoffier, G; Etiévant, A; Lemasson, M; Magno, LA; Manta, S; Roman, FS | 1 |
Miller, DK; Oelrichs, CE; Simonyi, A; Sun, GY | 1 |
Yun, J | 1 |
Chu, Z; Dang, YH; Liang, XP; Liu, P; Xing, B; Zhao, Y | 1 |
Harada, A; Kimura, H; Miyamoto, M; Suzuki, H; Suzuki, K | 1 |
Iwase, Y; Iwata, N; Mori, T; Murata, A; Suzuki, T | 1 |
Abe, T; Blencowe, BJ; Ip, JY; Kitaichi, K; Miyakawa, T; Nakagawa, S; Nashiki, C; Pan, Q; Sone, M; Takao, K; Yanaka, K | 1 |
Brown, RW; Harrod, SB; Lacy, RT; Mactutus, CF; Morgan, AJ | 1 |
Ago, Y; Hasebe, S; Hashimoto, H; Imoto, E; Matsuda, T; Takuma, K; Tanaka, T; Umehara, C | 1 |
Hikichi, H; Maehara, S; Ohta, H; Okuda, S; Satow, A | 1 |
Abe, M; Ago, Y; Arikawa, S; Matsuda, T; Takuma, K; Yano, K; Yata, M | 1 |
Iwata, K; Iwata, Y; Matsuzaki, H; Mori, N; Nakahara, D; Nakamura, K; Shinmura, C; Suda, S; Sugihara, G; Suzuki, K; Takei, N; Tsuchiya, KJ; Ueki, T; Wakuda, T; Yamamoto, S | 1 |
Abe, M; Egashira, N; Fujiwara, M; Ishibashi, A; Iwasaki, K; Manome, N; Mishima, K; Nishimura, R; Nogami, A; Oishi, R; Takasaki, K; Takata, J; Tashiro, R; Uchida, N | 1 |
Abe, M; Baba, A; Hashimoto, H; Köves, K; Kubo, M; Kuroda, M; Shibasaki, Y; Shintani, N; Tsuchida, R | 1 |
Benham, RS; Blutstein, T; Hadjimarkou, MM; Holder, MK; McCarthy, MM; Mong, JA; Zup, SL | 1 |
Gulley, JM; Hall, DA; Powers, JP | 1 |
Hagiwara, H; Hashimoto, K; Iyo, M | 1 |
Nishio, M; Watanabe, Y | 1 |
Chen, YC; Lai, WS | 1 |
Phelps, G; Sabol, KE; Speaker, HA | 1 |
Brodney, MA; Candler, J; Doran, AC; Duplantier, AJ; Efremov, IV; Evrard, E; Ganong, AH; Haas, JA; Hanks, AN; Jenza, K; Kraus, K; Lazzaro, JT; Maklad, N; McCarthy, SA; Qian, W; Rogers, BN; Rottas, MD; Schmidt, CJ; Siuciak, JA; Tingley, FD; Zhang, AQ; Zhang, L | 1 |
Ago, Y; Araki, R; Baba, A; Chaki, S; Hashimoto, H; Hiramatsu, N; Kawasaki, T; Matsuda, T; Nakazato, A; Onoe, H; Takuma, K; Yano, K | 1 |
Ago, Y; Kita, Y; Matsuda, T; Takuma, K; Tanaka, T; Tokumoto, H | 1 |
Masuo, Y; Rakwal, R; Shibato, J | 1 |
Han, W; Qi, J; Song, M; Wang, F; Wu, C; Yang, J; Zhang, L; Zhao, S | 1 |
Dong, H; Dong, Z; Gong, Z; He, Z; Yan, L; Yong, Z | 1 |
Kuroki, Y; Nishio, M; Watanabe, Y | 1 |
Furukawa, H; Mishina, M; Miyamoto, Y; Mori, H; Nabeshima, T; Nagai, T; Noda, Y; Yamada, K | 1 |
Matsuoka, N; Mutoh, S; Shirakawa, K; Tada, M | 1 |
Chun, W; Chung, H; Jang, CG; Jhoo, JH; Jhoo, WK; Kim, HC; Kwon, YS; Nabeshima, T; Shin, EJ; Sung, YE; Wie, MB | 1 |
Ishido, M; Masuo, Y; Morita, M; Niki, E; Oka, S | 1 |
Ballard, ME; Bennani, YL; Bitner, RS; Browman, KE; Buckley, MJ; Cowart, MD; Decker, MW; Drescher, KU; Esbenshade, TA; Faghih, R; Fox, GB; Hancock, AA; Komater, VA; Krueger, KM; Lemaire, M; Marsh, K; Miner, H; Pan, JB; Porsolt, RD; Radek, RJ; Rueter, LE; Sullivan, JP; Wetter, J; Yao, BB; Zhang, M | 1 |
Kitanaka, J; Kitanaka, N; Takemura, M | 1 |
Casteel, SW; Dopheide, MM; Miller, DK; Smith, SM | 1 |
Inoue, K; Koizumi, S; Miyatake, M; Narita, M; Shibasaki, M; Suzuki, T; Tsuda, M; Yajima, Y | 1 |
Hayashi, K; Inden, M; Inoue, K; Kim, DH; Kitamura, Y; Nishimura, K; Qi, M; Shimohama, S; Sumi, S; Takata, K; Taniguchi, T; Tsuchiya, D; Yanagisawa, D; Yoshimoto, K | 1 |
Ehrman, LA; Fienberg, AA; Greengard, P; Gudelsky, GA; Reed, TM; Schaefer, TL; Vorhees, CV; Williams, MT | 1 |
Ishido, M; Masuo, Y; Morita, M; Nagashima, K; Niki, E; Sawa, H | 1 |
Kelly, MA; Low, MJ; Phillips, TJ; Rubinstein, M | 1 |
Itoh, Y; Nishibori, M; Oishi, R; Saeki, K | 1 |
Hamada, K; Maeda, H; Takigawa, M; Tominaga, H | 1 |
Kataoka, Y; Kiyota, Y; Nakanishi, H; Oota, H; Shibata, K; Shibata, S; Ueki, S; Watanabe, S; Yamamoto, T | 1 |
Arai, E; Kobayashi, M; Nakajima, H; Shigehara, R; Shimada, M; Totsuka, Y | 1 |
Hori, Y; Ohnishi, M; Sakurai, K; Shibuya, T; Watanabe, Y; Yato, M | 1 |
Larson, J; LeDuc, BQ; Lynch, G; Nguyen, A; Quach, CN; Rogers, GA | 1 |
Cho, DH; Hong, YT; Jang, CG; Kim, HS; Oh, KW; Oh, S; Park, WK; Rheu, HM; Seong, YH | 1 |
Furuya, Y; Niidome, T; Nishizawa, Y; Ogura, H; Teramoto, T; Yamanishi, Y | 1 |
Hamada, K; Shiratani, T; Takenouchi, K; Takigawa, M; Wang, H | 1 |
Kato, K; Kobayashi, M; Niwa, S; Ono, M; Shishido, K; Shishido, T | 1 |
Kameda, K; Koyama, T; Kusumi, I; Miura, J; Suzuki, K; Tanaka, T | 1 |
Marshall, JF; O'Dell, SJ | 1 |
Araki, H; Futagami, K; Gomita, Y; Kawasaki, H; Kobayashi, Y; Yamamoto, T | 1 |
Oishi, R; Okada, K; Saeki, K | 1 |
Aoki, S; Imai, E; Kobayashi, M; Koshikawa, N | 1 |
Ellinwood, EH | 1 |
Matthies, H; Ott, T | 1 |
65 other study(ies) available for methamphetamine and Hyperactivity, Motor
Article | Year |
---|---|
ADHD symptoms induced by prenatal methamphetamine exposure.
Topics: Animals; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Female; Hyperkinesis; Male; Methamphetamine; Pregnancy; Prenatal Exposure Delayed Effects; Rats, Wistar | 2019 |
Recombinant Adeno-Associated Virus-Mediated Expression of Methamphetamine Antibody Attenuates Methamphetamine-Induced Hyperactivity in Mice.
Topics: Amphetamine-Related Disorders; Animals; Antibodies, Neutralizing; Dependovirus; HEK293 Cells; Humans; Hyperkinesis; Immunization, Passive; Male; Methamphetamine; Mice; Mice, Inbred ICR | 2017 |
The antipsychotic-like effects in rodents of YQA31 involve dopamine D3 and 5-HT1A receptor.
Topics: Animals; Antipsychotic Agents; Benzothiazoles; Cognition Disorders; Disease Models, Animal; Dizocilpine Maleate; Hyperkinesis; Male; Methamphetamine; Mice; Mice, Inbred C57BL; Mice, Knockout; Piperazines; Pyridines; Receptor, Serotonin, 5-HT1A; Receptors, Dopamine D3; Recognition, Psychology | 2017 |
Brain Renin-Angiotensin System Blockade Attenuates Methamphetamine-Induced Hyperlocomotion and Neurotoxicity.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Cell Line, Tumor; Corpus Striatum; Humans; Hyperkinesis; Losartan; Male; Methamphetamine; Mice, Inbred C57BL; Mice, Knockout; Receptor, Angiotensin, Type 1; Receptors, Dopamine D3; Renin-Angiotensin System; Telmisartan; Up-Regulation | 2018 |
GAL
Topics: Alcohol Drinking; Animals; Apomorphine; Central Nervous System Depressants; Central Nervous System Stimulants; Choice Behavior; Conditioning, Operant; Dizocilpine Maleate; Dopamine Agonists; Drug-Seeking Behavior; Emotions; Ethanol; Excitatory Amino Acid Antagonists; Fear; Female; Hyperkinesis; Interpersonal Relations; Male; Maze Learning; Methamphetamine; Mice, Knockout; Motor Activity; Phenotype; Receptor, Galanin, Type 3; Reflex, Startle; Self Administration; Sensory Gating; Spatial Memory | 2019 |
A sex- and region-specific role of Akt1 in the modulation of methamphetamine-induced hyperlocomotion and striatal neuronal activity: implications in schizophrenia and methamphetamine-induced psychosis.
Topics: Animals; Antipsychotic Agents; Behavior, Animal; Benzazepines; Disease Models, Animal; Estradiol; Estrogens; Female; Hyperkinesis; Male; Methamphetamine; Mice; Mice, Inbred C57BL; Mice, Knockout; Neostriatum; Neurons; Proto-Oncogene Proteins c-akt; Psychoses, Substance-Induced; Raclopride; Schizophrenia; Sex Factors | 2014 |
The novel recreational drug 3,4-methylenedioxypyrovalerone (MDPV) is a potent psychomotor stimulant: self-administration and locomotor activity in rats.
Topics: Animals; Behavior, Animal; Benzodioxoles; Body Temperature Regulation; Designer Drugs; Dose-Response Relationship, Drug; Hyperkinesis; Infusions, Intravenous; Injections, Subcutaneous; Male; Methamphetamine; Motor Activity; Psychomotor Agitation; Psychotropic Drugs; Pyrrolidines; Random Allocation; Rats; Rats, Wistar; Self Administration; Stereotypic Movement Disorder; Substance-Related Disorders; Synthetic Cathinone | 2013 |
Netrin-1 receptor-deficient mice show age-specific impairment in drug-induced locomotor hyperactivity but still self-administer methamphetamine.
Topics: Age Factors; Animals; Behavior, Animal; Central Nervous System Stimulants; Conditioning, Operant; Cues; DCC Receptor; Dose-Response Relationship, Drug; Drug-Seeking Behavior; Hyperkinesis; Male; Methamphetamine; Mice; Mice, Inbred C57BL; Motor Activity; Netrin Receptors; Receptors, Cell Surface; Self Administration; Tumor Suppressor Proteins | 2013 |
Cuprizone short-term exposure: astrocytic IL-6 activation and behavioral changes relevant to psychosis.
Topics: Animals; Astrocytes; Brain; Central Nervous System Stimulants; Chelating Agents; Copper; Cuprizone; Disease Models, Animal; Gene Expression Regulation; Glial Fibrillary Acidic Protein; Hallucinogens; Hyperkinesis; Interleukin-6; Male; Methamphetamine; Mice; Mice, Inbred C57BL; Phencyclidine; Psychotic Disorders; Time Factors | 2013 |
Dissociations between cognitive and motor effects of psychostimulants and atomoxetine in hyperactive DAT-KO mice.
Topics: Amphetamine; Analysis of Variance; Animals; Atomoxetine Hydrochloride; Central Nervous System Stimulants; Cognition; Dopamine Plasma Membrane Transport Proteins; Dose-Response Relationship, Drug; Hyperkinesis; Maze Learning; Methamphetamine; Mice; Mice, Inbred C57BL; Motor Activity; Norepinephrine; Propylamines; Psychomotor Performance; Serotonin; Serotonin Agents; Smell | 2014 |
Subchronic apocynin treatment attenuates methamphetamine-induced dopamine release and hyperactivity in rats.
Topics: Acetophenones; Animals; Anti-Inflammatory Agents, Non-Steroidal; Dopamine; Dose-Response Relationship, Drug; Hyperkinesis; Male; Methamphetamine; Motor Activity; Rats; Rats, Sprague-Dawley | 2014 |
L-tetrahydropalmatine inhibits methamphetamine-induced locomotor activity via regulation of 5-HT neuronal activity and dopamine D3 receptor expression.
Topics: Animals; Behavior, Animal; Berberine Alkaloids; Central Nervous System Stimulants; Corpus Striatum; Dopamine Antagonists; Hyperkinesis; Male; Methamphetamine; Mice, Inbred ICR; Motor Activity; Rats, Sprague-Dawley; Receptors, Dopamine D3; Serotonin; Serotonin Antagonists | 2014 |
Valproate Inhibits Methamphetamine Induced Hyperactivity via Glycogen Synthase Kinase 3β Signaling in the Nucleus Accumbens Core.
Topics: Animals; Behavior, Animal; Central Nervous System Stimulants; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Hyperkinesis; Male; Methamphetamine; Microinjections; Motor Activity; Nucleus Accumbens; Phosphorylation; Rats; Rats, Sprague-Dawley; Serine; Signal Transduction; Valproic Acid | 2015 |
TAK-063, a PDE10A Inhibitor with Balanced Activation of Direct and Indirect Pathways, Provides Potent Antipsychotic-Like Effects in Multiple Paradigms.
Topics: Animals; Antipsychotic Agents; Brain; Corpus Striatum; Cyclic AMP; Cyclic GMP; Dizocilpine Maleate; Dopamine; Dose-Response Relationship, Drug; Hyperkinesis; Male; Methamphetamine; Mice, Inbred C57BL; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Prepulse Inhibition; Pyrazoles; Pyridazines; Quinolines; Rats, Sprague-Dawley | 2016 |
Brain site- and transmitter-dependent actions of methamphetamine, morphine and antipsychotics.
Topics: Animals; Antipsychotic Agents; Brain; Central Nervous System Stimulants; Dose-Response Relationship, Drug; Hyperkinesis; Male; Methamphetamine; Mice; Microinjections; Morphine; Motor Activity; Narcotics; Neurotransmitter Agents | 2016 |
Gomafu lncRNA knockout mice exhibit mild hyperactivity with enhanced responsiveness to the psychostimulant methamphetamine.
Topics: Alternative Splicing; Animals; Behavior Rating Scale; Cells, Cultured; Dopamine; Gene Expression Profiling; Gene Knockout Techniques; Gene Regulatory Networks; Hyperkinesis; Methamphetamine; Mice; Neurons; Nucleus Accumbens; RNA, Long Noncoding; Sequence Analysis, RNA; Sympathomimetics | 2016 |
Intravenous Prenatal Nicotine Exposure Alters METH-Induced Hyperactivity, Conditioned Hyperactivity, and BDNF in Adult Rat Offspring.
Topics: Aging; Animals; Behavior, Animal; Brain-Derived Neurotrophic Factor; Dopamine; Female; Hyperkinesis; Male; Methamphetamine; Motor Activity; Nicotine; Pregnancy; Prenatal Exposure Delayed Effects | 2016 |
Role of Prefrontal Serotonergic and Dopaminergic Systems in Encounter-Induced Hyperactivity in Methamphetamine-Sensitized Mice.
Topics: 5,7-Dihydroxytryptamine; Animals; Central Nervous System Stimulants; Desipramine; Dopamine; Dopamine Agents; Enzyme Inhibitors; Hyperkinesis; Locomotion; Male; Methamphetamine; Mice; Microdialysis; Oxidopamine; Prefrontal Cortex; Proto-Oncogene Proteins c-fos; Serotonin; Serotonin Agents; Social Behavior; Time Factors | 2017 |
Antipsychotic property of a muscarinic receptor agonist in animal models for schizophrenia.
Topics: Animals; Antipsychotic Agents; Central Nervous System Stimulants; Clozapine; Dose-Response Relationship, Drug; Haloperidol; Hyperkinesis; Male; Methamphetamine; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Motor Activity; Muscarinic Agonists; Nicotine; Nicotinic Agonists; Oxotremorine; Rats; Rats, Sprague-Dawley; Reflex, Startle; Schizophrenic Psychology | 2008 |
Role of prefrontal dopaminergic neurotransmission in glucocorticoid receptor-mediated modulation of methamphetamine-induced hyperactivity.
Topics: Adrenalectomy; Animals; Dopamine; Hydroxycorticosteroids; Hyperkinesis; Male; Methamphetamine; Mice; Motor Activity; Prefrontal Cortex; Receptors, Glucocorticoid; Synaptic Transmission | 2009 |
Perinatal asphyxia reduces dentate granule cells and exacerbates methamphetamine-induced hyperlocomotion in adulthood.
Topics: Age Factors; Aging; Animals; Animals, Newborn; Asphyxia; Behavior, Animal; Cell Count; Central Nervous System Stimulants; Cerebellar Nuclei; Cesarean Section; Female; Hyperkinesis; Methamphetamine; Models, Biological; Motor Activity; Obstetric Labor Complications; Pregnancy; Rats; Rats, Sprague-Dawley | 2008 |
Yokukansan inhibits social isolation-induced aggression and methamphetamine-induced hyperlocomotion in rodents.
Topics: Aggression; Animals; Drugs, Chinese Herbal; Hyperkinesis; Male; Methamphetamine; Mice; Rats; Rats, Wistar; Social Isolation; Stress, Psychological | 2009 |
An antihyperkinetic action by the serotonin 1A-receptor agonist osemozotan co-administered with psychostimulants or the non-stimulant atomoxetine in mice.
Topics: Adrenergic Uptake Inhibitors; Amphetamine; Animals; Atomoxetine Hydrochloride; Central Nervous System Stimulants; Dioxanes; Dioxoles; Dose-Response Relationship, Drug; Drug Interactions; Hyperkinesis; Male; Methamphetamine; Mice; Mice, Inbred ICR; Piperazines; Propylamines; Pyridines; Receptor, Serotonin, 5-HT1A; Serotonin 5-HT1 Receptor Agonists; Serotonin 5-HT1 Receptor Antagonists; Serotonin Antagonists; Serotonin Receptor Agonists | 2009 |
Methamphetamine facilitates female sexual behavior and enhances neuronal activation in the medial amygdala and ventromedial nucleus of the hypothalamus.
Topics: Amygdala; Animals; Central Nervous System Stimulants; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Female; Hyperkinesis; Methamphetamine; Neurons; Oncogene Proteins v-fos; Rats; Rats, Sprague-Dawley; Sex Characteristics; Sexual Behavior, Animal; Synaptic Transmission; Tyrosine 3-Monooxygenase; Ventromedial Hypothalamic Nucleus | 2010 |
Blockade of D1 dopamine receptors in the medial prefrontal cortex attenuates amphetamine- and methamphetamine-induced locomotor activity in the rat.
Topics: Amphetamine; Analysis of Variance; Animals; Benzazepines; Catheters, Indwelling; Dopamine; Dopamine Agents; Dopamine Antagonists; Dose-Response Relationship, Drug; Hyperkinesis; Male; Methamphetamine; Motor Activity; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Serotonin; Serotonin Antagonists; Spiro Compounds; Sulfonamides | 2009 |
Mithramycin protects against dopaminergic neurotoxicity in the mouse brain after administration of methamphetamine.
Topics: 3,4-Dihydroxyphenylacetic Acid; Analysis of Variance; Animals; Behavior, Animal; Chromatography, High Pressure Liquid; Corpus Striatum; Dopamine; Dopamine Plasma Membrane Transport Proteins; Dose-Response Relationship, Drug; Drug Interactions; Fever; Hyperkinesis; Immunohistochemistry; Male; Methamphetamine; Mice; Motor Activity; Neuroprotective Agents; Plicamycin; Protein Synthesis Inhibitors | 2009 |
Hippocampal leptin suppresses methamphetamine-induced hyperlocomotion.
Topics: Animals; Dose-Response Relationship, Drug; Enzyme Activation; Hippocampus; Hyperkinesis; Janus Kinases; Leptin; Methamphetamine; Mice; Mice, Inbred Strains; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Receptors, Leptin; Signal Transduction; STAT Transcription Factors | 2010 |
Behavioural phenotyping of dopamine transporter knockdown mice using local small interference RNA.
Topics: Animals; Behavior, Animal; Dopamine Plasma Membrane Transport Proteins; Gene Knockdown Techniques; Hyperkinesis; Male; Methamphetamine; Mice; Mice, Inbred C57BL; Microinjections; Phenotype; RNA, Small Interfering; Substantia Nigra; Ventral Tegmental Area | 2010 |
Relationship between methamphetamine-induced behavioral activation and hyperthermia.
Topics: Analysis of Variance; Animals; Behavior, Animal; Body Temperature; Dose-Response Relationship, Drug; Fever; Hyperkinesis; Male; Methamphetamine; Motor Activity; Rats; Rats, Sprague-Dawley | 2010 |
1-[(1-methyl-1H-imidazol-2-yl)methyl]-4-phenylpiperidines as mGluR2 positive allosteric modulators for the treatment of psychosis.
Topics: Allosteric Regulation; Animals; Antipsychotic Agents; Biological Availability; Brain; Bridged Bicyclo Compounds, Heterocyclic; Cell Line; Dogs; Humans; Hyperkinesis; Imidazoles; In Vitro Techniques; Methamphetamine; Mice; Microsomes, Liver; Models, Molecular; Piperidines; Protein Conformation; Radioligand Assay; Rats; Receptors, Metabotropic Glutamate; Stereoisomerism; Structure-Activity Relationship | 2011 |
Activation of metabotropic glutamate 2/3 receptors attenuates methamphetamine-induced hyperlocomotion and increase in prefrontal serotonergic neurotransmission.
Topics: Animals; Bridged Bicyclo Compounds; Dicarboxylic Acids; Hyperkinesis; Male; Methamphetamine; Mice; Mice, Inbred Strains; Prefrontal Cortex; Receptors, Metabotropic Glutamate; Serotonin; Synaptic Transmission | 2011 |
Lithium attenuates methamphetamine-induced hyperlocomotion and behavioral sensitization via modulation of prefrontal monoamine release.
Topics: Animals; Behavior, Animal; Dopamine; Dopamine Uptake Inhibitors; Hyperkinesis; Lithium Chloride; Male; Methamphetamine; Mice; Motor Activity; Prefrontal Cortex; Receptor, Serotonin, 5-HT1A; Serotonin | 2012 |
ADHD animal model characterization: transcriptomics and proteomics analyses.
Topics: Animals; Animals, Newborn; Attention Deficit Disorder with Hyperactivity; Behavior, Animal; Brain; Disease Models, Animal; Electrophoresis, Gel, Two-Dimensional; Female; Hyperkinesis; Methamphetamine; Oligonucleotide Array Sequence Analysis; Oxidopamine; Pregnancy; Proteomics; Rats; Rats, Wistar; Transcriptome | 2012 |
NMDA receptors in the medial prefrontal cortex and the dorsal hippocampus regulate methamphetamine-induced hyperactivity and extracellular amino acid release in mice.
Topics: Amino Acids; Animals; Blotting, Western; Central Nervous System Stimulants; Excitatory Amino Acid Agonists; Extracellular Space; gamma-Aminobutyric Acid; Glutamic Acid; Hippocampus; Hyperkinesis; Kainic Acid; Male; Methamphetamine; Mice; Microdialysis; N-Methylaspartate; Neural Pathways; Prefrontal Cortex; Receptors, N-Methyl-D-Aspartate; Vesicular Glutamate Transport Protein 2 | 2012 |
Chicago sky blue 6B, a vesicular glutamate transporters inhibitor, attenuates methamphetamine-induced hyperactivity and behavioral sensitization in mice.
Topics: Animals; Animals, Outbred Strains; Behavior, Addictive; Central Nervous System Sensitization; Drug Interactions; Hyperkinesis; Injections, Intraventricular; Male; Methamphetamine; Mice; Motor Activity; Trypan Blue; Vesicular Glutamate Transport Proteins | 2013 |
Role of hippocampal alpha(2A)-adrenergic receptor in methamphetamine-induced hyperlocomotion in the mouse.
Topics: Adrenergic alpha-Antagonists; Adrenergic Uptake Inhibitors; Animals; Animals, Outbred Strains; Dose-Response Relationship, Drug; Drug Administration Routes; GTP-Binding Protein alpha Subunits, Gi-Go; Heterotrimeric GTP-Binding Proteins; Hippocampus; Hyperkinesis; Methamphetamine; Mice; Oligodeoxyribonucleotides, Antisense; Receptors, Adrenergic, alpha-2; Time Factors; Yohimbine | 2003 |
Behavioural adaptations to addictive drugs in mice lacking the NMDA receptor epsilon1 subunit.
Topics: Adaptation, Physiological; Animals; Behavior, Animal; Binding Sites; Binding, Competitive; Brain; Brain Chemistry; Dose-Response Relationship, Drug; Drug Tolerance; Excitatory Amino Acid Antagonists; Hyperkinesis; Methamphetamine; Mice; Mice, Knockout; Morphine; Narcotic Antagonists; Phencyclidine; Receptors, N-Methyl-D-Aspartate; Substance-Related Disorders; Synaptic Transmission | 2004 |
Combined treatment of quetiapine with haloperidol in animal models of antipsychotic effect and extrapyramidal side effects: comparison with risperidone and chlorpromazine.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Administration, Oral; Animals; Antipsychotic Agents; Basal Ganglia Diseases; Catalepsy; Chlorpromazine; Dibenzothiazepines; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Evaluation, Preclinical; Drug Synergism; Drug Therapy, Combination; Haloperidol; Hyperkinesis; Injections, Intraperitoneal; Male; Methamphetamine; Mice; Piperazines; Pyridines; Quetiapine Fumarate; Receptor, Serotonin, 5-HT1A; Risperidone; Schizophrenia; Serotonin 5-HT1 Receptor Agonists; Serotonin 5-HT1 Receptor Antagonists | 2004 |
PAP 9704, a Korean herbal medicine attenuates methamphetamine-induced hyperlocomotion via adenosine A2A receptor stimulation in mice.
Topics: Animals; Hyperkinesis; Korea; Locomotion; Male; Methamphetamine; Mice; Mice, Inbred BALB C; Plant Preparations; Plants, Medicinal; Receptor, Adenosine A2A | 2004 |
Motor activity and gene expression in rats with neonatal 6-hydroxydopamine lesions.
Topics: Animals; Animals, Newborn; Brain Chemistry; Catecholamines; Central Nervous System Stimulants; Chromatography, High Pressure Liquid; Disease Models, Animal; Electrochemistry; Gene Expression; Gene Expression Regulation, Developmental; Hyperkinesis; Immunohistochemistry; Ion Channels; Male; Methamphetamine; Motor Activity; Neurons; Neuropeptides; Oligonucleotide Array Sequence Analysis; Oxidopamine; Rats; Receptors, Cell Surface; Tyrosine 3-Monooxygenase | 2004 |
Pharmacological properties of ABT-239 [4-(2-{2-[(2R)-2-Methylpyrrolidinyl]ethyl}-benzofuran-5-yl)benzonitrile]: II. Neurophysiological characterization and broad preclinical efficacy in cognition and schizophrenia of a potent and selective histamine H3 re
Topics: Aging; Animals; Avoidance Learning; Benzofurans; Central Nervous System Stimulants; Cognition Disorders; Dose-Response Relationship, Drug; Drinking; Electroencephalography; Histamine Antagonists; Hyperkinesis; Male; Maze Learning; Methamphetamine; Mice; Mice, Inbred DBA; Microdialysis; Neurons; Neurotransmitter Agents; Pyrrolidines; Rats; Rats, Inbred SHR; Receptors, Histamine H3; Reflex, Startle; Schizophrenia; Social Behavior | 2005 |
Inhibition of methamphetamine-induced hyperlocomotion in mice by clorgyline, a monoamine oxidase-a inhibitor, through alteration of the 5-hydroxytriptamine turnover in the striatum.
Topics: Animals; Clorgyline; Corpus Striatum; Dose-Response Relationship, Drug; Drug Administration Schedule; Hyperkinesis; Male; Methamphetamine; Mice; Mice, Inbred ICR; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Neural Pathways; Nucleus Accumbens; Selegiline; Serotonin | 2005 |
Dietary cadmium exposure attenuates D-amphetamine-evoked [3H]dopamine release from striatal slices and methamphetamine-induced hyperactivity.
Topics: Animals; Brain; Cadmium; Central Nervous System Stimulants; Dextroamphetamine; Diet; Dopamine; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Hyperkinesis; Male; Methamphetamine; Motor Activity; Neostriatum; Potassium Chloride; Rats; Rats, Sprague-Dawley | 2005 |
Long-lasting change in brain dynamics induced by methamphetamine: enhancement of protein kinase C-dependent astrocytic response and behavioral sensitization.
Topics: Amphetamine-Related Disorders; Animals; Animals, Newborn; Astrocytes; Behavior, Animal; Brain; Cells, Cultured; Central Nervous System Stimulants; Coculture Techniques; Disease Models, Animal; Gyrus Cinguli; Hyperkinesis; Male; Methamphetamine; Mice; Mice, Inbred ICR; Morphine; Narcotics; Nerve Degeneration; Neuronal Plasticity; Nucleus Accumbens; Protein Kinase C; Up-Regulation | 2005 |
Transplantation of mouse embryonic stem cell-derived neurons into the striatum, subthalamic nucleus and substantia nigra, and behavioral recovery in hemiparkinsonian rats.
Topics: Animals; Basal Ganglia; Behavior, Animal; Brain Tissue Transplantation; Cell Count; Corpus Striatum; Denervation; Disease Models, Animal; Graft Survival; Growth Cones; Hyperkinesis; Male; Methamphetamine; Mice; Neurons; Oxidopamine; Parkinsonian Disorders; Pluripotent Stem Cells; Rats; Rats, Wistar; Recovery of Function; Stem Cell Transplantation; Substantia Nigra; Subthalamic Nucleus | 2005 |
Phosphodiesterase 1B differentially modulates the effects of methamphetamine on locomotor activity and spatial learning through DARPP32-dependent pathways: evidence from PDE1B-DARPP32 double-knockout mice.
Topics: Analysis of Variance; Animals; Anxiety; Central Nervous System Stimulants; Cyclic Nucleotide Phosphodiesterases, Type 1; Dopamine and cAMP-Regulated Phosphoprotein 32; Female; Hyperkinesis; Male; Maze Learning; Methamphetamine; Mice; Mice, Inbred C57BL; Mice, Knockout; Motor Activity; Phosphoric Diester Hydrolases; Signal Transduction; Spatial Behavior | 2006 |
Behavioural characteristics and gene expression in the hyperactive wiggling (Wig) rat.
Topics: Adrenergic Agents; Analysis of Variance; Animals; Animals, Congenic; Animals, Newborn; Behavior, Animal; Carrier Proteins; Central Nervous System Stimulants; Circadian Rhythm; GABA Plasma Membrane Transport Proteins; gamma-Aminobutyric Acid; Gene Expression; Gene Expression Profiling; Hyperkinesis; Mesencephalon; Methamphetamine; Oligonucleotide Array Sequence Analysis; Oxidopamine; Rats; Receptor, Adenosine A2A; Time Factors; Tyrosine 3-Monooxygenase | 2007 |
Role of dopamine D1-like receptors in methamphetamine locomotor responses of D2 receptor knockout mice.
Topics: Amphetamine-Related Disorders; Animals; Benzazepines; Central Nervous System Stimulants; Dopamine Antagonists; Female; Hyperkinesis; Male; Methamphetamine; Mice; Mice, Inbred C57BL; Mice, Knockout; Motor Activity; Receptors, Dopamine D1; Receptors, Dopamine D2 | 2008 |
Neuronal histamine inhibits methamphetamine-induced locomotor hyperactivity in mice.
Topics: Animals; Histamine; Humans; Hyperkinesis; Male; Methamphetamine; Mice; Mice, Inbred Strains; Motor Activity; Neurons | 1984 |
[Effects of lithium salt on intracranial self-stimulation and methamphetamine-induced hyperactivity in rats].
Topics: Animals; Humans; Hyperkinesis; Hypothalamus; Lithium; Male; Methamphetamine; Rats; Rats, Inbred Strains; Self Stimulation | 1983 |
[Behavioral and electroencephalographic effects of zopiclone, a cyclopyrrolone derivative].
Topics: Aggression; Agonistic Behavior; Animals; Anticonvulsants; Azabicyclo Compounds; Conflict, Psychological; Drug Synergism; Electroencephalography; Humans; Hyperkinesis; Hypnotics and Sedatives; Male; Methamphetamine; Mice; Motor Activity; Piperazines; Rabbits; Rats | 1983 |
[Effect of alpha-methyl-para-tyrosine on "methamphetamine-induced sterotype and hypermotility" of reserpinized rats (author's transl)].
Topics: alpha-Methyltyrosine; Animals; Humans; Hyperkinesis; Male; Methamphetamine; Methyltyrosines; Rats; Rats, Inbred Strains; Reserpine; Stereotyped Behavior | 1981 |
Inhibitory effects of newly synthesized Ser-contained GABA-peptides administered into either caudate putamen or amygdala on methamphetamine-induced hyperactivity.
Topics: Amygdala; Animals; Dose-Response Relationship, Drug; GABA Modulators; Hyperkinesis; Male; Methamphetamine; Microinjections; Peptides; Putamen; Rats; Rats, Wistar; Time Factors | 1995 |
Effects of an AMPA receptor modulator on methamphetamine-induced hyperactivity in rats.
Topics: Animals; Dopamine Agents; Half-Life; Hippocampus; Hyperkinesis; In Vitro Techniques; Male; Methamphetamine; Piperidines; Rats; Rats, Sprague-Dawley; Receptors, AMPA; Stereotyped Behavior; Synaptic Transmission | 1996 |
Inhibition by ginsenosides Rb1 and Rg1 of methamphetamine-induced hyperactivity, conditioned place preference and postsynaptic dopamine receptor supersensitivity in mice.
Topics: Adrenergic Agents; Animals; Behavior, Animal; Central Nervous System Agents; Conditioning, Psychological; Ginsenosides; Hyperkinesis; Male; Methamphetamine; Mice; Mice, Inbred ICR; Receptors, Dopamine; Saponins | 1998 |
Peptide N- and P/Q-type Ca2+ blockers inhibit stimulant-induced hyperactivity in mice.
Topics: Animals; Calcium Channel Blockers; Central Nervous System Stimulants; Hyperkinesis; Injections, Intraventricular; Methamphetamine; Methylphenidate; Mice; Motor Activity; omega-Agatoxin IVA; omega-Conotoxin GVIA; Peptides; Phencyclidine; Spider Venoms | 1998 |
Directed coherence of EEG on ICSS rats with methamphetamine-induced hyperactivity and stereotyped behavior.
Topics: Animals; Behavior, Animal; Central Nervous System Stimulants; Electroencephalography; Hyperkinesis; Male; Methamphetamine; Prefrontal Cortex; Rats; Rats, Wistar; Reinforcement, Psychology; Self Stimulation; Stereotyped Behavior; Ventral Tegmental Area | 2000 |
Glycine reduces novelty- and methamphetamine-induced locomotor activity in neonatal ventral hippocampal damaged rats.
Topics: Animals; Disease Models, Animal; Glycine; Hippocampus; Hyperkinesis; Ibotenic Acid; Methamphetamine; Motor Activity; Rats; Receptors, N-Methyl-D-Aspartate; Schizophrenia | 2001 |
Effects of lithium on dopamine D2 receptor expression in the rat brain striatum.
Topics: Animals; Antidepressive Agents; Dopamine; Dopamine Agents; Dopamine Antagonists; Drug Interactions; Gene Expression Regulation; Hyperkinesis; Levodopa; Lithium Carbonate; Male; Methamphetamine; Neostriatum; Neurons; Radioligand Assay; Rats; Rats, Wistar; Receptors, Dopamine D2; RNA, Messenger; Spiperone; Transcription, Genetic; Tritium | 2001 |
Effects of vibrissae removal on methamphetamine-induced damage to rat somatosensory cortical neurons.
Topics: Afferent Pathways; Animals; DNA-Binding Proteins; Early Growth Response Protein 1; Fluoresceins; Fluorescent Dyes; Functional Laterality; Hyperkinesis; Immediate-Early Proteins; Immunohistochemistry; Male; Methamphetamine; Nerve Degeneration; Neurons; Organic Chemicals; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley; RNA, Messenger; Sensory Deprivation; Somatosensory Cortex; Transcription Factors; Transcription, Genetic; Vibrissae | 2002 |
Effect of methamphetamine and imipramine on cerebral ischemia-induced hyperactivity in Mongolian gerbils.
Topics: Animals; Antidepressive Agents, Tricyclic; Brain Ischemia; Carotid Artery, Common; Central Nervous System Stimulants; Gerbillinae; Hippocampus; Hyperkinesis; Imipramine; Injections, Intraperitoneal; Male; Methamphetamine; Motor Activity | 2002 |
Inhibition by antimanic drugs of hyperactivity induced by methamphetamine-chlordiazepoxide mixture in mice.
Topics: Animals; Carbamazepine; Chlordiazepoxide; Hyperkinesis; Male; Methamphetamine; Mice; Motor Activity; Tranquilizing Agents | 1990 |
Effects of sulpiride injected into the dorsal striatum and the nucleus accumbens on dopamine-mediated oral stereotypy and hyperlocomotion in rats.
Topics: Animals; Apomorphine; Corpus Striatum; Dopamine; Hyperkinesis; Male; Methamphetamine; Mouth; Nucleus Accumbens; Rats; Rats, Inbred Strains; Receptors, Dopamine; Septal Nuclei; Stereotyped Behavior; Sulpiride | 1986 |
Effect of chronic methamphetamine intoxication in Rhesus monkeys.
Topics: Animals; Behavior, Animal; Exploratory Behavior; Female; Haplorhini; Humans; Hyperkinesis; Macaca; Male; Methamphetamine; Motor Activity; Psychoses, Substance-Induced | 1971 |
[Differentiation of neuroleptic and psychosedative effects in screening].
Topics: Animals; Chlordiazepoxide; Chlorpromazine; Depression, Chemical; Diazepam; Humans; Hyperkinesis; Hypnotics and Sedatives; Injections, Intraperitoneal; Male; Meprobamate; Methamphetamine; Mice; Motor Activity; Phenobarbital; Stimulation, Chemical; Tranquilizing Agents | 1969 |